MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
214.19B
Enterprise Value 3
235.33B
Trailing P/E
23.51
Forward P/E 1
15.02
PEG Ratio (5 yr expected) 1
1.73
Price/Sales (ttm)
4.66
Price/Book (mrq)
8.00
Enterprise Value/Revenue 3
5.12
Enterprise Value/EBITDA 6
13.02

Trading Information

Stock Price History

Beta (3Y Monthly) 0.55
52-Week Change 313.53%
S&P500 52-Week Change 318.11%
52 Week High 387.35
52 Week Low 370.89
50-Day Moving Average 383.91
200-Day Moving Average 383.17

Share Statistics

Avg Vol (3 month) 38.09M
Avg Vol (10 day) 37.5M
Shares Outstanding 52.55B
Float 2.54B
% Held by Insiders 10.08%
% Held by Institutions 178.28%
Shares Short (Oct 31, 2019) 419.86M
Short Ratio (Oct 31, 2019) 42.44
Short % of Float (Oct 31, 2019) 40.77%
Short % of Shares Outstanding (Oct 31, 2019) 40.78%
Shares Short (prior month Sep 30, 2019) 421.47M

Dividends & Splits

Forward Annual Dividend Rate 42.2
Forward Annual Dividend Yield 42.59%
Trailing Annual Dividend Rate 32.13
Trailing Annual Dividend Yield 32.51%
5 Year Average Dividend Yield 43.01
Payout Ratio 461.45%
Dividend Date 3Oct 7, 2019
Ex-Dividend Date 4Sep 13, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Feb 17, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 20.26%
Operating Margin (ttm)31.60%

Management Effectiveness

Return on Assets (ttm)10.78%
Return on Equity (ttm)30.86%

Income Statement

Revenue (ttm)45.97B
Revenue Per Share (ttm)17.80
Quarterly Revenue Growth (yoy)14.90%
Gross Profit (ttm)28.81B
EBITDA 18.08B
Net Income Avi to Common (ttm)9.31B
Diluted EPS (ttm)3.58
Quarterly Earnings Growth (yoy)-2.50%

Balance Sheet

Total Cash (mrq)8.02B
Total Cash Per Share (mrq)3.15
Total Debt (mrq)27.11B
Total Debt/Equity (mrq)100.69
Current Ratio (mrq)1.26
Book Value Per Share (mrq)10.52

Cash Flow Statement

Operating Cash Flow (ttm)12.24B
Levered Free Cash Flow (ttm)9.74B